Evidence map›Paper›PMID 26967262›Full record

ArticleJournal of the American Chemical Society2016

Fluorescence Monitoring of the Oxidative Repair of DNA Alkylation Damage by ALKBH3, a Prostate Cancer Marker.

Andrew A Beharry, Sandrine Lacoste, Timothy R O'Connor, Eric T Kool

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 59 citations in OpenAlex.

  1. Chemical science · 2024
    Article
  2. Review
  3. Chemical Tools for the Study of DNA Repair.Accounts of chemical research · 2022
    Article
  4. Physio-pathological effects of m6A modification and its potential contribution to melanoma.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2021
    Review
  5. Article
  6. Review
  7. NInternational journal of biological sciences · 2021
    Review
  8. Review
  9. Article
  10. Review
  11. The role of NMolecular cancer · 2020
    Review
  12. An Excimer Clamp for Measuring Damaged-Base Excision by the DNA Repair Enzyme NTH1.Angewandte Chemie (International ed. in English) · 2020
    Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Fluorescent Probes of DNA Repair.ACS chemical biology · 2018
    Review
  18. Potent and Selective Inhibitors of 8-Oxoguanine DNA Glycosylase.Journal of the American Chemical Society · 2018
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Andrew A BeharryDepartment of Chemistry, Stanford University , Stanford, California 94305, United States.
Sandrine LacosteDepartment of Cancer Biology, Beckman Research Institute , Duarte, California 91010, United States.
Timothy R O'ConnorDepartment of Cancer Biology, Beckman Research Institute , Duarte, California 91010, United States.
Eric T KoolDepartment of Chemistry, Stanford University , Stanford, California 94305, United States.
Beckman Research InstituteStanford University · US

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI XIWEI WU · 1985 to 2026
$86.3M
Transplant for Lymphoma:Therapy-Related LeukemiaP50CA107399 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI KWAK, LARRY W · 2004 to 2022
$35.5M
POLYFLUOROPHORES ASSEMBLED ON A DNA SCAFFOLDR01GM067201 · NIGMS · STANFORD UNIVERSITY · PI KOOL, ERIC T. · 2003 to 2011
$2.2M
Highly Reactive Hydrazone Chemistry: Orthogonal Modification in Cellular ContextsR01GM110050 · NIGMS · STANFORD UNIVERSITY · PI KOOL, ERIC T. · 2015 to 2018
$1.2M
NCI NIH HHS CA107399NCI NIH HHS CA176622NCI NIH HHS P30 CA033572NCI NIH HHS P30CA33572NCI NIH HHS P50 CA107399NIGMS NIH HHS GM067201NIGMS NIH HHS GM110050NIGMS NIH HHS R01 GM067201NIGMS NIH HHS R01 GM110050
6 · The paper itself

Abstract

The 2-oxoglutarate-dependent iron enzyme ALKBH3 is an antitumor target and a potential diagnostic marker for several tumor types, including prostate cancer. However, there is at present no simple way to measure this enzyme's activity. Here we describe a fluorogenic probe design (MAQ) that is directly responsive to ALKBH3 repair activity. It makes use of the fluorescence-quenching properties of 1-methyladenine; removal of the alkyl group results in a >10-fold light-up signal. The probe is specific for ALKBH3 over its related homologue ALKBH2 and can be used to identify and measure the effectiveness of enzyme inhibitors. Measurements of the enzyme substrate parameters show that MAQ displays Km and kcat values essentially the same as those of the native substrate. Finally, we show that the probe functions efficiently in cells, allowing imaging and quantitation of ALKBH3 activity by microscopy and flow cytometry. We expect that MAQ probes will be broadly useful in the study of the basic biology of ALKBH3 and in clinical cancer applications as well.

Indexed as

DNA DamageAdenineAlkB Homolog 3, Alpha-Ketoglutarate-Dependent DioxygenaseAnimalsAntineoplastic Agents, AlkylatingBiomarkers, TumorFluorescent DyesHumansKineticsMaleMiceOxidation-ReductionProstatic NeoplasmsSpectrometry, Fluorescence1-methyladenineAdenineALKBH3 protein, humanAlkB Homolog 3, Alpha-Ketoglutarate-Dependent DioxygenaseAntineoplastic Agents, AlkylatingBiomarkers, TumorFluorescent Dyes

Identifiers

PMID26967262
PMCPMC5105888
OpenAlexW2295682363

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.